site stats

Cytokinetics inc stock

WebMar 27, 2024 · Cytokinetics is committed to our mission of developing potential medicines that may improve the healthspan of people living with cardiovascular and neuromuscular diseases of impaired muscle function. … WebApr 10, 2024 · In 2024, Roche acquired Cytokinetics, Inc.'s SMA program, which is a muscle activator drug for SMA. This acquisition is part of Roche's effort to become a leading company in the SMA market.

Cytokinetics Incorporated (CYTK) Stock: A SWOT Analysis

WebApr 10, 2024 · Zacks Equity Research. April 10, 2024, 9:23 AM · 3 min read. It has been a rough year so far for late-stage biopharmaceutical company, Cytokinetics, Incorporated CYTK. Shares of the company have ... Web12 hours ago · Analysts have been eager to weigh in on the Healthcare sector with new ratings on Cytokinetics (CYTK – Research Report) and Neurocrine (NBIX – Research Report). TipRanks has tracked 36,000 ... michiana professional credit bureau https://lt80lightkit.com

Cytokinetics (CYTK) Dips 20% so Far in 2024 on Setbacks

WebStock Money Flow N/A PROFILE ( CYTK) Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle … WebMar 31, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential … WebApr 10, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential... how to check chromebook specs

CYTOKINETICS, INCORPORATED COMMON STOCK PURCHASE …

Category:Cytokinetics Stock Price Today - Investing.com

Tags:Cytokinetics inc stock

Cytokinetics inc stock

Cytokinetics (CYTK) Dips 20% so Far in 2024 on Setbacks

WebApr 20, 2024 · Is CYTK stock a buy? Hedge fund interest in Cytokinetics, Inc. (NASDAQ: CYTK) shares was flat at the end of last quarter. This is usually a negative indicator. Our calculations also showed... Web1 day ago · Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle …

Cytokinetics inc stock

Did you know?

WebCytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as … WebMar 31, 2024 · Cytokinetics Inc's market capitalization is $4.08 B by 94.63 M shares outstanding. Is Cytokinetics stock a Buy, Sell or Hold? Cytokinetics stock has …

Web12 hours ago · Analysts have been eager to weigh in on the Healthcare sector with new ratings on Cytokinetics (CYTK – Research Report) and Neurocrine (NBIX – Research … WebCytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for...

WebApr 7, 2024 · Latest Cytokinetics, Inc. Stock News As of April 06, 2024, Cytokinetics, Inc. had a $3.4 billion market capitalization, putting it in the 78th percentile of companies in … WebApr 9, 2024 · In other Cytokinetics news, CEO Robert I. Blum sold 12,500 shares of the stock in a transaction on Monday, March 6th. The stock was sold at an average price of …

WebApr 7, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Investors & Media Cytokinetics’ unparalleled expertise has kept it at the forefront of drug discovery and development for diseases impacting muscle performance.

WebApr 10, 2024 · Zacks Equity Research. April 10, 2024, 9:23 AM · 3 min read. It has been a rough year so far for late-stage biopharmaceutical company, Cytokinetics, Incorporated … how to check christmas tree lightsWebJul 19, 2024 · Cytokinetics Inc. (NASDAQ: CYTK) Change As Cytokinetics grows, it is riding positive news. The stock is up over $8 at press time, totaling more than a 45% change. Over the past year, the... how to check chromebook storagemichiana music togetherWebNov 29, 2024 · Cytokinetics, Inc. (CYTK) stock has gained 0.67% while the S&P 500 has fallen -0.43% as of 11:42 AM on Tuesday, Nov 29. CYTK is higher by $0.27 from the previous closing price of $40.09 on volume of 312,812 shares. Over the past year the S&P 500 is lower by -15.22% while CYTK is higher by 4.10%. how to check chrome historyWebWith a price/sales ratio of 34.58, CYTOKINETICS INC has a higher such ratio than 95.52% of stocks in our set. Equity multiplier, or assets relative to shareholders' equity, comes in at 35.83 for CYTOKINETICS INC; that's greater than it is for 99.05% of US stocks. michiana lawn and gardenWebApr 6, 2024 · Cytokinetics (NASDAQ:CYTK) has a market capitalization of $3.48 billion and generates $94.59 million in revenue each year. The biopharmaceutical company earns … how to check christmas tree light bulbsWebFind real-time CYTK - Cytokinetics Inc stock quotes, company profile, news and forecasts from CNN Business. ... Cytokinetics Inc (NASDAQ:CYTK) Real-Time Quotes. 35.41. … how to check chrome version